Drug makers dogged by rebate issue

Prospects have been grim for Korean pharmaceutical firms, as they are getting pressed by multinationals' increasing market presence and the government's pressure to lower drug costs. Generic drugs have long been the competitive edge for local makers, but even they are set to lose steam once the government cracks down on pharmaceutical firms offering rebates starting December.

During the parl...